# Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

> **NCT00412984** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20976 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DRUG:** warfarin
- **DRUG:** apixaban

## Key facts

- **NCT ID:** NCT00412984
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12-31
- **Primary completion:** 2011-05-25
- **Final completion:** 2011-05-25
- **Target enrollment:** 20976 (ACTUAL)
- **Last updated:** 2018-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412984, "Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00412984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*